Glenmede Trust CO Na Insmed Inc Transaction History

Glenmede Trust CO Na

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$31.45 - $40.54 $27,109 - $34,945	-862 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$26.0 - $34.5 $910 - $1,207	35 Added 4.23%	862 $27,000
Q2 2020 Aug 14, 2020	SELL	$14.11 - $29.42 $10,427 - $21,741	-739 Reduced 47.19%	827 $22,000
Q4 2018 Feb 14, 2019	BUY	$11.6 - $18.7 $14,964 - $24,123	1,290 Added 467.39%	1,566 $20,000
Q2 2018 Aug 15, 2018	BUY	$20.0 - $29.72 $5,520 - $8,202	276 New	276 $7,000

465

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.98B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.